HealthDay News — The US Food and Drug Administration (FDA) has removed one hurdle faced by patients with schizophrenia when filling prescriptions for the antipsychotic medication clozapine.

LTG-001, a selective inhibitor for treatment of acute pain, was granted Fast Track designation by the Food and Drug Administration (FDA).

Prescribing physical activity and exercise may be a "potent tool" for clinicians caring for older adults, according to investigators.

Loretta Ford, EdD, RN, PNP, NP-C, CRNP, FAAN, FAANP, co-founder of the nurse practitioner (NP) profession, built an extraordinary legacy over decades of service to patients, students, and clinicians.

The US government has ended funding for some 5800 global health programs, cutting off critical support for projects to millions of people globally.

For AI to improve efficiency, it must be developed with a clear focus on practical applications rather than unnecessary diagnostic tools and risk calculators. Artificial intelligence (AI) has the ...

During 30 months of follow-up, the researchers found that the weighted cumulative incidences of all-cause mortality and hospitalization were 5218 per 10 5 person-years (PY) and 16,334 per 10 5 PY, ...

The report highlights that generative AI must be designed to alleviate specific workflow inefficiencies, particularly time spent on electronic health records.

Beginning in late January and extending through February 2025, flu hospitalizations have been higher than any other week since before 2009.

The researchers found that the 5-year risks for revision among 3691 participants was 5.6% for patients in the weight gain or stable weight group compared with 3.9% in patient with greater than 10% ...

A retrospective study of data from patients aged 50 to 75 years in the Kaiser Permanente Northern California health system showed detection of colorectal cancer by colonoscopy fell by 4% in 2020 ...

Overall survival was significantly improved in patients treated with brentuximab vedotin plus lenalidomide/rituximab compared with placebo plus lenalidomide/rituximab ...